• DOI:10.1016/j.urolonc.2014.03.016
Corpus ID: 25658010

Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.

@article{Forauer2014CancerfreeSA,
  title={Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.},
  author={A. Forauer and B. Dewey and J. Seigne},
  journal={Urologic oncology},
  year={2014},
  volume={32 6},
  pages={
          869-76
        }
}

A. Forauer, B. Dewey, J. Seigne

Published 2014

Medicine

Urologic oncology

OBJECTIVES There are numerous reports describing the use of radiofrequency ablation (RFA) to treat renal cell carcinoma. Many series, however, describe heterogeneous populations, lack histologic descriptions, use various RFA systems, and indicate tumor destruction by different ablation end points. This study examined the outcomes of computed tomography-guided, impedance-based RFA of biopsy-proven renal cell carcinoma clinically staged as T1a with a minimum of 1 year of postablation follow-up… CONTINUE READING

View on PubMed

doi.org

Save to Library

Create Alert

Cite

Launch Research Feed